2 天之前 · We are committed to redefining healthcare: connecting the best of Health&Care for every provider, for every patient, for everyone. Imagine all the amazing things those two …

Every day, our more than 150,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

2025年1月10日 · Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also …

Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.

2020年9月23日 · NEW BRUNSWICK, N.J., September 23, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country …

2023年9月14日 · Patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address …

Development pipeline. Select programs in development, Phase 1 through Approval (removed after programs achieve approval in both US/EU) Learn more

2024年9月26日 · Reimagining how we discover and develop transformational treatments, accelerating the path from lab to life and advancing the standard of care.

2025年3月10日 · The J&J value. At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are …

We are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow. We will combine our science and technology with our …